Aims: The co-transmitter neuropeptide-Y (NPY) is released during high sympathetic drive, including ST-elevation myocardial infarction (STEMI), and can be a potent vasoconstrictor. We hypothesized that myocardial NPY levels correlate with reperfusion and subsequent recovery following primary percutaneous coronary intervention (PPCI), and sought to determine if and how NPY constricts the coronary microvasculature. Methods and results: Peripheral venous NPY levels were significantly higher in patients with STEMI (n = 45) compared to acute coronary syndromes/stable angina ( n = 48) or with normal coronary arteries (NC, n = 16). Overall coronary sinus (CS) and peripheral venous NPY levels were significantly positively correlated (r = 0.79). S...
Acute myocardial infarction (AMI) and the heart failure (HF) that often complicates this condition, ...
Aims The main aim of this study was to characterize changes in the left ventricular (LV) blood flow ...
Aims: A fractional flow reserve (FFR) value ≥0.90 after percutaneous coronary intervention (PCI) i...
Aims: Coronary microvascular dysfunction and/or vasospasm are potential causes of ischaemia in pat...
Aims : Necrotizing coronary vasculitis (NCV) is a rare entity usually associated to myocarditis whic...
MI/R results in marked cardiac contractile dysfunction and cell death. We previously discovered that...
Aims: In ventricular myocytes from humans and large mammals, the transverse and axial tubular sys...
Aims: To investigate myocardial fibrosis (MF) in a large series of severe aortic stenosis (AS) patie...
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Card...
AIMS: Myocardial fibrosis as detected by late gadolinium enhancement (LGE) on cardiac magnetic reson...
Aim We tested the hypothesis that metformin may regress left ventricular hypertrophy (LVH) in pat...
AIMS: To investigate the effect of high-dose iron vs. low-dose intravenous (IV) iron on myocardial i...
Copyright © 2017, Oxford University PressAims: Myocardial infarction (MI) is the leading cause of mo...
Aims The optimal method of revascularization for patients with left main coronary artery disease (L...
Aims: Risk estimation is important to motivate patients to adhere to treatment and to identify th...
Acute myocardial infarction (AMI) and the heart failure (HF) that often complicates this condition, ...
Aims The main aim of this study was to characterize changes in the left ventricular (LV) blood flow ...
Aims: A fractional flow reserve (FFR) value ≥0.90 after percutaneous coronary intervention (PCI) i...
Aims: Coronary microvascular dysfunction and/or vasospasm are potential causes of ischaemia in pat...
Aims : Necrotizing coronary vasculitis (NCV) is a rare entity usually associated to myocarditis whic...
MI/R results in marked cardiac contractile dysfunction and cell death. We previously discovered that...
Aims: In ventricular myocytes from humans and large mammals, the transverse and axial tubular sys...
Aims: To investigate myocardial fibrosis (MF) in a large series of severe aortic stenosis (AS) patie...
© The Author(s) 2018. Published by Oxford University Press on behalf of the European Society of Card...
AIMS: Myocardial fibrosis as detected by late gadolinium enhancement (LGE) on cardiac magnetic reson...
Aim We tested the hypothesis that metformin may regress left ventricular hypertrophy (LVH) in pat...
AIMS: To investigate the effect of high-dose iron vs. low-dose intravenous (IV) iron on myocardial i...
Copyright © 2017, Oxford University PressAims: Myocardial infarction (MI) is the leading cause of mo...
Aims The optimal method of revascularization for patients with left main coronary artery disease (L...
Aims: Risk estimation is important to motivate patients to adhere to treatment and to identify th...
Acute myocardial infarction (AMI) and the heart failure (HF) that often complicates this condition, ...
Aims The main aim of this study was to characterize changes in the left ventricular (LV) blood flow ...
Aims: A fractional flow reserve (FFR) value ≥0.90 after percutaneous coronary intervention (PCI) i...